Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 08:10:32 GMT 2023
by
admin
on
Sat Dec 16 08:10:32 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
P050J5FWC5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L03AB03
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
354711
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
||
|
FDA ORPHAN DRUG |
246107
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
||
|
WHO-VATC |
QL03AB03
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
||
|
LIVERTOX |
NBK548199
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/05/281
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5570
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
P-01579
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
5570
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
SUB14223MIG
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
P050J5FWC5
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
INTERFERON GAMMA
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
m6306
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID6037647
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
82115-62-6
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
C583
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY | |||
|
P050J5FWC5
Created by
admin on Sat Dec 16 08:10:32 GMT 2023 , Edited by admin on Sat Dec 16 08:10:32 GMT 2023
|
PRIMARY |
Glycosylation Link Type | Site |
---|---|
N | 1_25 |
N | 1_97 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT MAY BE PRESENT |
T lymphocytes secrete interferon gamma (IFN-γ) and IL-2 following co-culture with BCMA-expressing cells
|
||
|
PARENT -> CONSTITUENT MAY BE PRESENT |
secrete interferon gamma in esponse to CD22 expressing tumour cell lines
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET | |||
|
ACTIVATOR OF EXPRESSION->TARGET |
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
||
|
T-CELLS->EXPRESSED PROTEIN |
upon activation
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
||
|
INHIBITOR OF EXPRESSION->TARGET |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
The T lymphocytes secrete interferon gamma (IFN-γ)
following co-culture with BCMA-expressing cells
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
ACTIVATOR OF EXPRESSION->TARGET |
when co-cultured with CD70 expressing cell
IN-VITRO
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|